NO20051296L - Partielle og fullstendige agonister av A1-adenosinreseptorer - Google Patents

Partielle og fullstendige agonister av A1-adenosinreseptorer

Info

Publication number
NO20051296L
NO20051296L NO20051296A NO20051296A NO20051296L NO 20051296 L NO20051296 L NO 20051296L NO 20051296 A NO20051296 A NO 20051296A NO 20051296 A NO20051296 A NO 20051296A NO 20051296 L NO20051296 L NO 20051296L
Authority
NO
Norway
Prior art keywords
sup
optionally substituted
cycloalkyl
hydrogen
partial
Prior art date
Application number
NO20051296A
Other languages
English (en)
Norwegian (no)
Inventor
Jeff A Zablocki
Elfatih O Elzein
Venkata Palle
Xiaofen Li
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Publication of NO20051296L publication Critical patent/NO20051296L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO20051296A 2002-08-15 2005-03-14 Partielle og fullstendige agonister av A1-adenosinreseptorer NO20051296L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40371202P 2002-08-15 2002-08-15
US45009403P 2003-02-25 2003-02-25
PCT/US2003/025629 WO2004016635A2 (en) 2002-08-15 2003-08-15 Partial and full agonists of a1 adenosine receptors

Publications (1)

Publication Number Publication Date
NO20051296L true NO20051296L (no) 2005-05-13

Family

ID=31891396

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051296A NO20051296L (no) 2002-08-15 2005-03-14 Partielle og fullstendige agonister av A1-adenosinreseptorer

Country Status (15)

Country Link
US (2) US7022681B2 (ru)
EP (1) EP1537133B1 (ru)
JP (1) JP4596913B2 (ru)
KR (1) KR20050067384A (ru)
CN (1) CN100480255C (ru)
AT (1) ATE368048T1 (ru)
AU (1) AU2003263846B2 (ru)
CA (1) CA2495370A1 (ru)
DE (1) DE60315164T2 (ru)
ES (1) ES2288632T3 (ru)
MX (1) MXPA05001844A (ru)
NO (1) NO20051296L (ru)
NZ (1) NZ538590A (ru)
RU (1) RU2340623C2 (ru)
WO (1) WO2004016635A2 (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005009343A2 (en) * 2003-06-06 2005-02-03 Endacea, Inc. A1 adenosine receptor antogonists
CN101668768B (zh) * 2007-05-17 2012-08-29 吉利德帕洛阿尔托股份有限公司 制备a2a-腺苷受体激动剂及其多晶型物的方法
US20140357594A1 (en) * 2011-10-24 2014-12-04 Glaxosmithkline Intellectual Property (No.2) Limited New compounds
CR20170384A (es) * 2015-02-24 2017-11-16 Pfizer Derivados de nucleosidos sustituidos utiles como agentes antineoplasicos

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1254888A (en) * 1984-10-26 1989-05-30 Bharat Trivedi N.sup.6-bicycloadenosines
USRE36494E (en) * 1990-02-20 2000-01-11 Discovery Therapeutics, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
US5140015A (en) * 1990-02-20 1992-08-18 Whitby Research, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
US5278150A (en) * 1992-04-24 1994-01-11 Whitby Research, Inc. 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
AU2022597A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
AU4377397A (en) * 1996-10-14 1998-05-11 Novo Nordisk A/S Novel therapeutically active adenosine derivatives
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
US20040162422A1 (en) * 2001-03-20 2004-08-19 Adrian Hall Chemical compounds

Also Published As

Publication number Publication date
ES2288632T3 (es) 2008-01-16
RU2005106997A (ru) 2005-11-10
EP1537133B1 (en) 2007-07-25
RU2340623C2 (ru) 2008-12-10
EP1537133A2 (en) 2005-06-08
JP4596913B2 (ja) 2010-12-15
CN100480255C (zh) 2009-04-22
AU2003263846A1 (en) 2004-03-03
NZ538590A (en) 2006-10-27
JP2006505525A (ja) 2006-02-16
AU2003263846B2 (en) 2009-12-17
KR20050067384A (ko) 2005-07-01
US20040043960A1 (en) 2004-03-04
ATE368048T1 (de) 2007-08-15
CA2495370A1 (en) 2004-02-26
DE60315164D1 (de) 2007-09-06
US20060135467A1 (en) 2006-06-22
MXPA05001844A (es) 2005-04-19
WO2004016635A3 (en) 2004-04-08
WO2004016635A2 (en) 2004-02-26
US7022681B2 (en) 2006-04-04
DE60315164T2 (de) 2008-04-30
CN1675235A (zh) 2005-09-28

Similar Documents

Publication Publication Date Title
CY1112991T1 (el) ΠΑΡΑΓΩΓΑ ΙΝΔΟΛΗΣ Ή ΒΕΝΖΙΜΙΔΑΖΟΛΗΣ ΓΙΑ ΤΗ ΡΥΘΜΙΣΗ ΤΗΣ ΙκΒ ΚΙΝΑΣΗΣ ΚΑΙ ΕΝΔΙΑΜΕΣΑ ΠΡΟΪΟΝΤΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΟΥΣ
CY1107221T1 (el) Παραγωγα τριαζολιου ως ανταγωνιστες υποδοχεα ταχυκινινης
TW200716639A (en) Fused heterocyclic compounds
EA200600333A1 (ru) Производные индазола
DE60225671D1 (de) Pharmazeutisch wirksame piperidinderivate
RS53030B (en) 4-AMINO-2 (2,6-DIOXOPIPERIDIN-3-IL) ISOINDOLINE-1,3-DION COMPOUND OBTAINING PROCEDURE
CO5560547A2 (es) Metodos para la preparacion de compuestos de pirrolotriazina utiles como inhibidores de cinasa
CY1107001T1 (el) Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες
AU2002212598A1 (en) Pyridinone and pyridinethione derivatives having hiv inhibiting properties
TW200734337A (en) Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
NO20062032L (no) Derivater av N-[fenyl(pyrrolidin-2-yl)-metyl]benzamid og N-[(azepan-2-yl)fenylmetyl]benzamid, fremgangsmate for fremstilling derav og anvendelse derav i terapeutiske midler
NO20051296L (no) Partielle og fullstendige agonister av A1-adenosinreseptorer
AU2426602A (en) Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
UY26721A1 (es) Nuevos derivados de la fenilglicina
ES2175615T3 (es) Derivados de azaindol etilamina como agentes de union al receptor nicotinico de acetilcolina.
EA200971060A1 (ru) Гетероариламидные пиримидоновые производные
NZ552372A (en) Propane-1,3-dione derivative or its salt
IN2012DN03449A (ru)
EA200300629A1 (ru) Конденсированные производные пурина как антагонисты рецепторов аденозина a
ATE237612T1 (de) Benzofuranderivate
RS52518B (en) 4-ALCOXYPYRIDASINE DERIVATIVES AS A FAST DISSOCATING DOPAMINE 2 RECEPTOR ANTAGONISTS
ATE396158T1 (de) Frühhochfeste superbetonverflüssiger
WO2005061475A3 (en) Ornithine derivatives as prostaglandin e2 agonists or antagonists
FR2847899B1 (fr) Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique
HK1048319A1 (zh) 新的季銨化合物，其製備方法和其藥物用途

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application